Literature DB >> 19545671

The role of Foxp3+ regulatory T cells in kidney transplantation.

M Karczewski1, J Karczewski, A Kostrzewa, K Wiktorowicz, M Glyda.   

Abstract

Our project aimed to investigate the relation between the level of pretransplantation and posttransplantation peripheral CD4(+)CD25(+)Foxp3(+) T-regulatory lymphocytes (Tregs) and the development of acute rejection (AR) episodes in 44 patients after kidney transplantation. During the 6-month period following transplantation, AR was diagnosed in 11 patients. Peripheral blood samples were collected 1 day before and 10 days after transplantation and tested for concentrations of CD4(+)CD25(+)Foxp3(+) cells by means of flow cytometry. The pretransplantation analysis showed significantly lower mean levels of peripheral Tregs in AR patients versus control group (P < .05). A lower level of Tregs was also observed in nonrejection (NONAR) patients versus control group (P < .05); however, it was still higher than in the AR group (P < .05). The 10-day posttransplantation analysis showed a similar pattern; however, a significant increase in the concentration of peripheral Tregs in NONAR patients was observed (P < .05), whereas no change was recorded in AR patients (P > .05). We found lower pretransplantation levels of peripheral Tregs in both AR and NONAR groups, versus control group. The deficiency of peripheral Tregs in patients with end-stage renal failure might be due to the long-term inflammatory processes adversely affecting the peripheral regulatory mechanisms. However, significantly lower levels of Tregs observed in AR patients might also be related to genetic predispositions. Our observation suggests that the size and possibly the functionality of Tregs in the AR group was not sufficient to successfully control the immune response after kidney transplantation, leading to acute rejection episodes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545671     DOI: 10.1016/j.transproceed.2009.03.065

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience.

Authors:  Lin Zhou; Li-Chao Pan; Yong-Gen Zheng; Guo-Sheng Du; Xiao-Qian Fu; Zhi-Dong Zhu; Ji-Yong Song; Zhi-Jia Liu; Xiang-Zheng Su; Wen Chen; De-Hua Zheng; Long-Long Suo; Shao-Zhen Yang
Journal:  Oncol Lett       Date:  2018-07-27       Impact factor: 2.967

2.  Kidney Transplant Outcome Is Associated with Regulatory T Cell Population and Gene Expression Early after Transplantation.

Authors:  Magdalena Krajewska; Katarzyna Kościelska-Kasprzak; Dorota Kamińska; Marcelina Żabińska; Marta Myszka-Kozłowska; Agnieszka Gomułkiewicz; Piotr Dzięgiel; Marian Klinger
Journal:  J Immunol Res       Date:  2019-01-08       Impact factor: 4.818

3.  The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.

Authors:  Liang Ma; Huimao Zhang; Kebang Hu; Guoyue Lv; Yaowen Fu; Desalegn Admassu Ayana; Pingwei Zhao; Yanfang Jiang
Journal:  BMC Immunol       Date:  2015-09-23       Impact factor: 3.615

4.  Reduction of FoxP3+ Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.

Authors:  Lin Zhou; Li-Chao Pan; Yong-Gen Zheng; Xin-Xue Zhang; Zhi-Jia Liu; Xuan Meng; Hai-Da Shi; Guo-Sheng Du; Qiang He
Journal:  Ann Transl Med       Date:  2020-04

5.  Effects of Desflurane and Sevoflurane anesthesia on regulatory T cells in patients undergoing living donor kidney transplantation: a randomized intervention trial.

Authors:  Arpa Chutipongtanate; Sasichol Prukviwat; Nutkridta Pongsakul; Supanart Srisala; Nakarin Kamanee; Nuttapon Arpornsujaritkun; Goragoch Gesprasert; Nopporn Apiwattanakul; Suradej Hongeng; Wichai Ittichaikulthol; Vasant Sumethkul; Somchai Chutipongtanate
Journal:  BMC Anesthesiol       Date:  2020-08-27       Impact factor: 2.217

6.  PD-L1+NEUT, Foxp3+Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma.

Authors:  Lin Zhou; Jing Wang; Shao-Cheng Lyu; Li-Chao Pan; Xian-Jie Shi; Guo-Sheng Du; Qiang He
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.